This is a snippet of the transcript, sign up to read more.
Regarding consumption, chocolate companies are using pipeline stocks, but eventually, they will have to start putting high-priced beans equivalent products onto the market. Slowly, we will see this reflected in prices. Companies are aggressively reformulating their recipes. We have been involved in this process. Many have reduced pack sizes, as seen in the news, with 100-gram packs becoming 80 or 75 grams, without changing recipes, just adjusting pack sizes.
This is a snippet of the transcript, sign up to read more.
You will soon see reformulated products on the market. This is an internal process they will undertake without altering flavor and taste profiles. A lot of research is ongoing. Something that is not quite a compound or chocolate, but something in between, is under R&D and will likely enter the market.
This is a snippet of the transcript, sign up to read more.
Overall, all brands are reducing cocoa content in their products. This is the current situation, and going forward, maybe in March or April, after Easter, you will see some price increases on the shelves.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research